Amundi Asset Management US’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Amundi Asset Management US’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,000	Closed	-$167K	–	1701
2019 Q4	$167K	Hold	7,000	–	–	﹤0.01%	1506
2019 Q3	$188K	Buy	7,000 +1,500	+27%	+$42.1K	﹤0.01%	1474
2019 Q2	$149K	Sell	5,500 -26,413	-83%	-$828K	﹤0.01%	1523
2019 Q1	$1.11M	Sell	31,913 -487,287	-94%	-$14.1M	﹤0.01%	1196
2018 Q4	$10.1K	Buy	519,200 +67,300	+15%	+$1.38M	0.01%	654
2018 Q3	$12M	Buy	451,900 +248,800	+123%	+$8.12M	0.02%	688
2018 Q2	$7.67M	Buy	203,100 +28,241	+16%	+$1.08M	0.01%	808
2018 Q1	$5.71M	Buy	174,859 +66,900	+62%	+$2.94M	0.01%	822
2017 Q4	$5.26M	Buy	+107,959	New	+$5.46M	0.01%	829

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Amundi Asset Management US's PTLA Position: Q1 2020 in Review

Amundi Asset Management US sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 7,000 shares — an estimated $167K sold.

Amundi Asset Management US first reported a position in PTLA in Q4 2017 and held it in 9 quarters. The position peaked at $12M in Q3 2018. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

Amundi Asset Management US reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Amundi Asset Management US sold 7,000 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $167K.
Amundi Asset Management US first reported a position in Portola Pharmaceuticals, Inc. in Q4 2017 and held it in 9 quarters.
Amundi Asset Management US's Portola Pharmaceuticals, Inc. position peaked at $12M in Q3 2018.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Amundi Asset Management US's 13F filing for Q1 2020, filed 15 May 2020.